Iradimed (IRMD) EBT Growth (3y) (2016 - 2026)
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | EBT Growth (3y) (Qtr) |
|---|---|---|---|---|---|
| 1 | Abbott Laboratories | 152.82 Bn | 146.17 Bn | 6.27 Bn | -2.47% |
| 2 | Stryker | 115.07 Bn | 112.19 Bn | 3.81 Bn | 7.77% |
| 3 | Medtronic | 95.25 Bn | 87.08 Bn | 5.76 Bn | 0.70% |
| 4 | Boston Scientific | 71.38 Bn | 70.17 Bn | 3.61 Bn | 37.81% |
| 5 | Edwards Lifesciences | 51.08 Bn | 47.41 Bn | 1.29 Bn | 4.82% |
| 6 | Koninklijke Philips | 29.38 Bn | 26.07 Bn | 2.07 Bn | 32.11% |
| 7 | Dexcom | 28.84 Bn | 27.72 Bn | 750.30 Mn | 61.06% |
| 8 | GE HealthCare Technologies | 28.56 Bn | 26.49 Bn | 1.98 Bn | -2.57% |
| 9 | Steris | 20.71 Bn | 20.30 Bn | 697.10 Mn | 14.40% |
| 10 | Iradimed | 1.17 Bn | 1.11 Bn | 16.81 Mn | 21.33% |
Historic Data
Download Data| Date | Value |
|---|---|
| Mar 31, 2026 | 21.33% |
| Dec 31, 2025 | 18.32% |
| Sep 30, 2025 | 19.87% |
| Jun 30, 2025 | 20.58% |
| Mar 31, 2025 | 24.78% |
| Dec 31, 2024 | 26.78% |
| Sep 30, 2024 | 27.54% |
| Jun 30, 2024 | 50.00% |
| Mar 31, 2024 | 43.58% |
| Dec 31, 2023 | 104.48% |
| Sep 30, 2023 | 100.58% |
| Jun 30, 2023 | 56.32% |
| Mar 31, 2023 | 73.30% |
| Dec 31, 2022 | 25.95% |
| Sep 30, 2022 | 17.25% |
| Jun 30, 2022 | 19.43% |
| Mar 31, 2022 | 23.96% |
| Dec 31, 2021 | 18.40% |
| Sep 30, 2021 | 27.56% |
| Jun 30, 2021 | 2.93% |
| Mar 31, 2021 | 16.25% |
| Dec 31, 2020 | -13.64% |
| Sep 30, 2020 | 52.30% |
| Jun 30, 2020 | -117.92% |
| Mar 31, 2020 | 81.73% |
| Dec 31, 2019 | 15.83% |
| Sep 30, 2019 | 0.50% |
| Jun 30, 2019 | -9.73% |
| Mar 31, 2019 | -22.96% |
| Dec 31, 2018 | -17.29% |
| Sep 30, 2018 | -23.02% |
| Jun 30, 2018 | -14.65% |
| Mar 31, 2018 | -21.28% |
| Dec 31, 2017 | 82.21% |
| Sep 30, 2017 | -17.31% |
| Jun 30, 2017 | -40.09% |
| Mar 31, 2017 | -31.08% |
| Dec 31, 2016 | 30.53% |
| Sep 30, 2016 | 90.49% |
| Jun 30, 2016 | 60.78% |